Logo image of ULCC

FRONTIER GROUP HOLDINGS INC (ULCC) Stock Fundamental Analysis

USA - NASDAQ:ULCC - US35909R1086 - Common Stock

4.08 USD
-0.18 (-4.23%)
Last: 10/17/2025, 4:50:44 PM
4.1091 USD
+0.03 (+0.71%)
After Hours: 10/17/2025, 4:50:44 PM
Fundamental Rating

2

Taking everything into account, ULCC scores 2 out of 10 in our fundamental rating. ULCC was compared to 21 industry peers in the Passenger Airlines industry. Both the profitability and financial health of ULCC have multiple concerns. While showing a medium growth rate, ULCC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ULCC had negative earnings in the past year.
In the past year ULCC has reported a negative cash flow from operations.
ULCC had negative earnings in 4 of the past 5 years.
In the past 5 years ULCC reported 4 times negative operating cash flow.
ULCC Yearly Net Income VS EBIT VS OCF VS FCFULCC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

The Return On Assets of ULCC (-0.52%) is comparable to the rest of the industry.
ULCC has a Return On Equity (-6.72%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.52%
ROE -6.72%
ROIC N/A
ROA(3y)0.11%
ROA(5y)-1.68%
ROE(3y)1.49%
ROE(5y)-17.47%
ROIC(3y)N/A
ROIC(5y)N/A
ULCC Yearly ROA, ROE, ROICULCC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

In the last couple of years the Profit Margin of ULCC has declined.
In the last couple of years the Operating Margin of ULCC has declined.
ULCC has a Gross Margin (55.48%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ULCC has declined.
The Profit Margin and Operating Margin are not available for ULCC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.48%
OM growth 3YN/A
OM growth 5Y-33.83%
PM growth 3YN/A
PM growth 5Y-25.97%
GM growth 3Y5.57%
GM growth 5Y-1.83%
ULCC Yearly Profit, Operating, Gross MarginsULCC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

2

2. Health

2.1 Basic Checks

ULCC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ULCC has been increased compared to 1 year ago.
ULCC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ULCC has an improved debt to assets ratio.
ULCC Yearly Shares OutstandingULCC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
ULCC Yearly Total Debt VS Total AssetsULCC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.44, we must say that ULCC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ULCC (0.44) is worse than 61.90% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that ULCC is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.46, ULCC belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z 0.44
ROIC/WACCN/A
WACC9.2%
ULCC Yearly LT Debt VS Equity VS FCFULCC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

A Current Ratio of 0.41 indicates that ULCC may have some problems paying its short term obligations.
ULCC's Current ratio of 0.41 is on the low side compared to the rest of the industry. ULCC is outperformed by 71.43% of its industry peers.
ULCC has a Quick Ratio of 0.41. This is a bad value and indicates that ULCC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.36, ULCC is doing worse than 76.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.36
ULCC Yearly Current Assets VS Current LiabilitesULCC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ULCC have decreased strongly by -255.56% in the last year.
Measured over the past years, ULCC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.53% on average per year.
ULCC shows a small growth in Revenue. In the last year, the Revenue has grown by 4.60%.
The Revenue has been growing by 8.52% on average over the past years. This is quite good.
EPS 1Y (TTM)-255.56%
EPS 3YN/A
EPS 5Y-20.53%
EPS Q2Q%-321.43%
Revenue 1Y (TTM)4.6%
Revenue growth 3Y22.37%
Revenue growth 5Y8.52%
Sales Q2Q%-4.52%

3.2 Future

Based on estimates for the next years, ULCC will show a very strong growth in Earnings Per Share. The EPS will grow by 39.97% on average per year.
ULCC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.04% yearly.
EPS Next Y-418.09%
EPS Next 2Y-30.74%
EPS Next 3Y39.97%
EPS Next 5YN/A
Revenue Next Year-0.13%
Revenue Next 2Y6.44%
Revenue Next 3Y9.04%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ULCC Yearly Revenue VS EstimatesULCC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
ULCC Yearly EPS VS EstimatesULCC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ULCC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ULCC is valuated quite expensively with a Price/Forward Earnings ratio of 36.98.
ULCC's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.85, ULCC is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 36.98
ULCC Price Earnings VS Forward Price EarningsULCC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ULCC indicates a slightly more expensive valuation: ULCC is more expensive than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 42.13
ULCC Per share dataULCC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as ULCC's earnings are expected to grow with 39.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-30.74%
EPS Next 3Y39.97%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ULCC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FRONTIER GROUP HOLDINGS INC

NASDAQ:ULCC (10/17/2025, 4:50:44 PM)

After market: 4.1091 +0.03 (+0.71%)

4.08

-0.18 (-4.23%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners28.18%
Inst Owner Change-0.01%
Ins Owners33.72%
Ins Owner Change-0.29%
Market Cap930.89M
Analysts68.89
Price Target5.74 (40.69%)
Short Float %38.36%
Short Ratio4.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-47.21%
Min EPS beat(2)-85.03%
Max EPS beat(2)-9.4%
EPS beat(4)1
Avg EPS beat(4)-20.75%
Min EPS beat(4)-85.03%
Max EPS beat(4)87.63%
EPS beat(8)5
Avg EPS beat(8)12.23%
EPS beat(12)9
Avg EPS beat(12)14.74%
EPS beat(16)12
Avg EPS beat(16)15.45%
Revenue beat(2)0
Avg Revenue beat(2)-4.22%
Min Revenue beat(2)-4.7%
Max Revenue beat(2)-3.73%
Revenue beat(4)0
Avg Revenue beat(4)-2.83%
Min Revenue beat(4)-4.7%
Max Revenue beat(4)-0.2%
Revenue beat(8)0
Avg Revenue beat(8)-3.2%
Revenue beat(12)0
Avg Revenue beat(12)-3.19%
Revenue beat(16)2
Avg Revenue beat(16)-2.89%
PT rev (1m)18.42%
PT rev (3m)19.82%
EPS NQ rev (1m)-0.9%
EPS NQ rev (3m)-2608.36%
EPS NY rev (1m)0.88%
EPS NY rev (3m)-288.49%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-7.18%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-3.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 36.98
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 1.84
P/tB 1.94
EV/EBITDA 42.13
EPS(TTM)-0.32
EYN/A
EPS(NY)0.11
Fwd EY2.7%
FCF(TTM)-1.61
FCFYN/A
OCF(TTM)-1.26
OCFYN/A
SpS16.56
BVpS2.22
TBVpS2.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.52%
ROE -6.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.48%
FCFM N/A
ROA(3y)0.11%
ROA(5y)-1.68%
ROE(3y)1.49%
ROE(5y)-17.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-33.83%
PM growth 3YN/A
PM growth 5Y-25.97%
GM growth 3Y5.57%
GM growth 5Y-1.83%
F-Score2
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA 10.17
Cap/Depr 100%
Cap/Sales 2.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.41
Quick Ratio 0.36
Altman-Z 0.44
F-Score2
WACC9.2%
ROIC/WACCN/A
Cap/Depr(3y)99.56%
Cap/Depr(5y)83.64%
Cap/Sales(3y)1.56%
Cap/Sales(5y)1.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-255.56%
EPS 3YN/A
EPS 5Y-20.53%
EPS Q2Q%-321.43%
EPS Next Y-418.09%
EPS Next 2Y-30.74%
EPS Next 3Y39.97%
EPS Next 5YN/A
Revenue 1Y (TTM)4.6%
Revenue growth 3Y22.37%
Revenue growth 5Y8.52%
Sales Q2Q%-4.52%
Revenue Next Year-0.13%
Revenue Next 2Y6.44%
Revenue Next 3Y9.04%
Revenue Next 5YN/A
EBIT growth 1Y11.11%
EBIT growth 3YN/A
EBIT growth 5Y-28.19%
EBIT Next Year-1469.83%
EBIT Next 3Y268.44%
EBIT Next 5YN/A
FCF growth 1Y-286.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-540%
OCF growth 3YN/A
OCF growth 5YN/A